Cargando…
Neurocognitive benchmarks following transplant for emerging cerebral adrenoleukodystrophy
OBJECTIVE: To quantify benchmark treatment outcomes that may be enabled by newborn screening surveillance for X-linked adrenoleukodystrophy (ALD), we report neurocognitive, neuropsychiatric, and MRI change for boys who underwent hematopoietic stem cell transplant (HSCT) at initial stages of demyelin...
Autores principales: | Pierpont, Elizabeth I., Nascene, David R., Shanley, Ryan, Kenney-Jung, Daniel L., Ziegler, Richard S., Miller, Weston P., Gupta, Ashish O., Lund, Troy C., Orchard, Paul J., Eisengart, Julie B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455349/ https://www.ncbi.nlm.nih.gov/pubmed/32616675 http://dx.doi.org/10.1212/WNL.0000000000009929 |
Ejemplares similares
-
Differential outcomes for frontal versus posterior demyelination in childhood cerebral adrenoleukodystrophy
por: Gupta, Ashish O., et al.
Publicado: (2021) -
Post‐transplant adaptive function in childhood cerebral adrenoleukodystrophy
por: Pierpont, Elizabeth I., et al.
Publicado: (2018) -
Association between APOE4 and biomarkers in cerebral adrenoleukodystrophy
por: Orchard, Paul J., et al.
Publicado: (2019) -
Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
por: Orchard, Paul J, et al.
Publicado: (2011) -
Failure of intrathecal allogeneic mesenchymal stem cells to halt progressive demyelination in two boys with cerebral adrenoleukodystrophy
por: Gupta, Ashish, et al.
Publicado: (2020)